Working… Menu

Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02471222
Recruitment Status : Completed
First Posted : June 15, 2015
Last Update Posted : August 8, 2017
Information provided by (Responsible Party):
Adamas Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 2016
Actual Study Completion Date : June 2016
Certification/Extension First Submitted : August 1, 2017